Magellan Health Receivables

Magellan Health (MGLN) currently reports a receivables of $830M as of September 2021. That compares with $770M in the prior-year period — up 7.5% year over year. Use the charts on this page to explore Magellan Health's receivables history and peer comparisons.

Magellan Health's receivables increased from $770M to $830M — a 7.5% year-over-year increase (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Magellan Health reported $830M in receivables as of September 2021. That compares with $770M in the prior-year period — up 7.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $830M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Magellan Health, and consider following MGLN for alerts when major investors trade the stock.

Magellan Health is classified in the Healthcare sector. On receivables, it currently shows $830M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MGLN with unrelated industries.